134 related articles for article (PubMed ID: 3523065)
1. Estimating pharmacy level prescription drug acquisition costs for third-party reimbursement.
Kreling DH; Kirk KW
Med Care; 1986 Jul; 24(7):590-600. PubMed ID: 3523065
[TBL] [Abstract][Full Text] [Related]
2. Third-party reimbursement for generic prescription drugs: The prevalence of below-cost reimbursement in an environment of maximum allowable cost-based reimbursement.
Murry L; Gerleman B; Urick B; Urmie J
J Am Pharm Assoc (2003); 2018; 58(4):421-425. PubMed ID: 29861152
[TBL] [Abstract][Full Text] [Related]
3. Assessing changes in third-party gross margin for a single community pharmacy.
Urick BY; Urmie JM; Doucette WR; McDonough RP
J Am Pharm Assoc (2003); 2014; 54(1):27-34. PubMed ID: 24362541
[TBL] [Abstract][Full Text] [Related]
4. Analysis of costs to dispense prescriptions in independently owned, closed-door long-term care pharmacies.
Carroll NV; Rupp MT; Holdford DA
J Manag Care Spec Pharm; 2014 Mar; 20(3):291-300. PubMed ID: 24564809
[TBL] [Abstract][Full Text] [Related]
5. Estimating a reasonable reimbursement for community pharmacies in third-party programs.
Carroll NV
Manag Care Interface; 1999 Feb; 12(2):73-6, 79-80. PubMed ID: 10346189
[TBL] [Abstract][Full Text] [Related]
6. The association of insurance type with costs of dispensed drugs.
Mott DA; Kreling DH
Inquiry; 1998; 35(1):23-35. PubMed ID: 9597015
[TBL] [Abstract][Full Text] [Related]
7. Effect of a change in third party reimbursement rate on prescription gross margin.
Ganther JM; Kreling DH
J Am Pharm Assoc (Wash); 1999; 39(3):346-52. PubMed ID: 10363461
[TBL] [Abstract][Full Text] [Related]
8. Case study using descriptive analysis to estimate hidden costs in processing third party prescriptions.
Herrier RN; Spencer JR; Davis CD
J Am Pharm Assoc (Wash); 2000; 40(5):658-65. PubMed ID: 11029847
[TBL] [Abstract][Full Text] [Related]
9. Assessing potential prescription reimbursement changes: estimated acquisition costs in Wisconsin.
Kreling DH
Health Care Financ Rev; 1989; 10(3):67-75. PubMed ID: 10313098
[TBL] [Abstract][Full Text] [Related]
10. Who cares what it costs to dispense a Medicaid prescription?
Lamphere-Thorpe JA; Johnston WP; Kilpatrick KE; Norwood GJ
Health Care Financ Rev; 1994; 15(3):9-24. PubMed ID: 10137800
[TBL] [Abstract][Full Text] [Related]
11. Profitability, third-party reimbursement, and access to community pharmacies.
Carroll NV; Miederhoff PA; Waters LW
Clin Ther; 1996; 18(4):703-15; discussion 702. PubMed ID: 8879898
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the claim percent gross margin earned by Texas community independent pharmacies for dual-eligible beneficiary claims before and after Medicare Part D.
Winegar AL; Shepherd MD; Lawson KA; Richards KM
J Am Pharm Assoc (2003); 2009; 49(5):617-22. PubMed ID: 19748868
[TBL] [Abstract][Full Text] [Related]
13. A study of the additional costs of dispensing workers' compensation prescriptions.
Schafermeyer KW
Res Social Adm Pharm; 2007 Mar; 3(1):123-36. PubMed ID: 17350561
[TBL] [Abstract][Full Text] [Related]
14. State Medicaid pharmacy payments and their relation to estimated costs.
Adams EK; Kreling DH; Gondek K
Health Care Financ Rev; 1994; 15(3):25-42. PubMed ID: 10137796
[TBL] [Abstract][Full Text] [Related]
15. Managing Medicaid drug expenditures.
Sudovar SG; Rein SD
J Health Hum Resour Adm; 1978 Nov; 1(2):200-30. PubMed ID: 10308767
[No Abstract] [Full Text] [Related]
16. Pharmacists' views of an experience in capitation reimbursement under the Iowa Medicaid drug program.
Cirn JT
Contemp Pharm Pract; 1980; 3(3):180-8. PubMed ID: 10297946
[TBL] [Abstract][Full Text] [Related]
17. Compliance among pharmacies in California with a prescription-drug discount program for Medicare beneficiaries.
Lewis JH; Schonlau M; Muñoz JA; Asch SM; Rosen MR; Yang H; Escarce JJ
N Engl J Med; 2002 Mar; 346(11):830-5. PubMed ID: 11893795
[TBL] [Abstract][Full Text] [Related]
18. How removing prescription drugs from reimbursement lists increases the pharmaceutical expenditures for alternatives.
Gür Ali O; Topaler B
Eur J Health Econ; 2011 Dec; 12(6):553-62. PubMed ID: 20717700
[TBL] [Abstract][Full Text] [Related]
19. Patient counseling in community pharmacy and its relationship with prescription payment methods and practice settings.
Raisch DW
Ann Pharmacother; 1993 Oct; 27(10):1173-9. PubMed ID: 8251681
[TBL] [Abstract][Full Text] [Related]
20. Estimating the impact of Medicare part D on the profitability of independent community pharmacies.
Carroll NV
J Manag Care Pharm; 2008 Oct; 14(8):768-79. PubMed ID: 18983206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
